Navigation Links
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Date:10/18/2007

CARLSBAD, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that it has added a new diabetes drug targeting the sodium dependent glucose transporter type 2 (SGLT2) to its development pipeline. ISIS 388626, a generation 2.2 antisense drug that acts in the kidney to increase glucose excretion, complements Isis' existing pipeline of drugs in development for the treatment of diabetes, each of which act upon targets in the liver through distinct mechanisms to improve insulin sensitivity, reduce glucose production, or affect other metabolic aspects of this complex disease.

The productivity of antisense technology has allowed Isis to rapidly evaluate many potential targets for treatment of complex metabolic diseases such as diabetes and obesity in well established animal models. To date, Isis has analyzed the effects of inhibiting over 120 distinct gene targets in animals, and the efficiency of the drug discovery process should continue to provide a rich source of promising drugs with which to populate Isis' future pipeline. ISIS 388626 is the fourth development candidate to come out of Isis' extensive metabolic disease drug discovery program.

"We think ISIS 388626 is an exciting addition to our portfolio that offers a kidney-based mechanism, which will complement our other diabetes drugs in development," said Sanjay Bhanot, M.D., Ph.D., Vice President of Metabolic Diseases Research & Development, Isis Pharmaceuticals. "This is the first kidney target that we have approached with our second-generation drugs, and we are quite encouraged by what we have seen in the animal models. We know that antisense drugs distribute most readily to the liver, kidney, fat cells, b
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... who show signs of chronic inflammation in non-cancerous prostate ... having prostate cancer than those with no inflammation, according ... from the Johns Hopkins Kimmel Cancer Center. , The ... for men with so-called high-grade prostate cancer those ... indicating the presence of the most aggressive and rapidly ...
(Date:4/17/2014)... One of the most popular vaccine brands for ... doctors may be overlooking some cost factors when choosing ... more expensive option, according to a new study by ... to administer can be driven by numerous factors," says ... a professor of computer science and of mathematics at ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... University School of Medicine in St. Louis working with ... cells long thought to be responsible for type 1 ... immune cells from isolated insulin-making structures in the pancreas ... immune cells, known as dendritic cells, "red-handed": carrying insulin ...
... Retired Air Force,Colonel Mike Turner, a Democratic candidate for ... Care Countdown" inspired by MSNBC host,Keith Olbermann. Today is ... and a key architect of Hillary Clinton,s,notorious 1993 health ... to tell 10th District voters what, if any, plan ...
... Aid through Dubai Cares, DUBAI, United Arab Emirates, ... Maktoum, Vice President and Prime Minister of the,U.A.E. and ... structures to be used as schools and shelter to ... donation. The,official death toll currently stands at 22,000, with ...
... Calif., May 9 Dakim, Inc., announced,today that ... in,health and fitness, has signed on as a ... [m]Power Cognitive Fitness System, joining the,company,s efforts to ... is a touch screen-based brain workout program designed,to ...
... 9 Roche announced today that Sarah,Vidal, M.P.H., ... as a 2008 Rising Star by the Healthcare ... on May 8,2008 in New York City., ... combination of,confidence, energy, experience, contagious enthusiasm and respect ...
... to provide more visible presence for world,s largest surgical,organization, ... (ACS) today broke ground for a new home for ... presence on Capitol Hill. The,10-story, class A office building, ... the first quarter of 2010. ACS headquarters will remain ...
Cached Medicine News:Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 2Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 3Health News:Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown 2Health News:Dubai Provides Aid for Cyclone Nargis Victims In Myanmar 2Health News:Physical Fitness 'Godfather' Jack LaLanne Turns to Brain Fitness, Becoming Ambassador for Dakim's [m]Power System 2Health News:Roche's Vidal Honored as 2008 HBA Rising Star 2Health News:American College of Surgeons Breaks Ground on New Office Building on Capitol Hill 2
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... - NEOPHARM, Inc.,(Nasdaq: NEOL) today reported findings ... metastatic colorectal cancer patients with its,drug product ... While the interim analysis of data following ... patients demonstrated,disease stabilization, the study did not ...
... OTCBB: CHKT, VANCOUVER, April 02, 2007 /PRNewswire-FirstCall/ ... biotechnology company,developing chemokine-based therapies to treat cancer, ... the,University of Texas M. D. Anderson Cancer ... metastasis with a CXCR4,antagonist in a mouse ...
Cached Medicine Technology:NeoPharm Provides Update on LE-SN38 Program 2M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 2M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 3M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 4
... The Signature Edition GOLD Infusion System ... customer input, as well as the ... Human factors design refers to the ... controls and displays engineered to reduce ...
... clinician documentation and electronic medical record (EMR) ... specific needs of intensive care units and ... clinical functionality has secured its place as ... critical care, and its the most reliable ...
... Electronic Health Record (EHR/EMR) ... (WfMS) Specialties that we ... Immunology, Cardiology, Dermatology, Family ... Neurology, Neurosurgery, Obstetrics and ...
... Clinic Pro Software developed a touchscreen EHR ... spring. While a user can choose to ... practitioner to maintain eye contact while recording ... Clinic Pro EHR also runs on a ...
Medicine Products: